Evidence map›Paper›PMID 31578667›Full record

ArticleJournal of natural medicines2020

Metabolomic profiling of Saposhnikoviae Radix from Mongolia by LC-IT-TOF-MS/MS and multivariate statistical analysis.

Zolboo Batsukh, Kazufumi Toume, Batkhuu Javzan, Kohei Kazuma, Shao-Qing Cai, Shigeki Hayashi, Nobuo Kawahara, Takuro Maruyama, Katsuko Komatsu

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of natural medicines, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Chemotaxonomic Classification ofMolecules (Basel, Switzerland) · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Polysaccharides Derived fromOncoTargets and therapy · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zolboo BatsukhDepartment of Medicinal Resources, Institute of Natural Medicine, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan.
Kazufumi ToumeDepartment of Medicinal Resources, Institute of Natural Medicine, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan.ORCID http://orcid.org/0000-0002-3315-145X
Batkhuu JavzanSchool of Engineering and Applied Sciences, National University of Mongolia, Ulaanbaatar-46, Mongolia.
Kohei KazumaDepartment of Medicinal Resources, Institute of Natural Medicine, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan.ORCID http://orcid.org/0000-0002-2556-7260
Shao-Qing CaiSchool of Pharmaceutical Sciences, Peking University, 38 Xue-yuan Road, Haidian District, Beijing, 100191, People's Republic of China.
Shigeki HayashiResearch Center for Medicinal Plant Resources, National Institutes of Biomedical Innovation, Health and Nutrition, 1-2 Hachimandai, Tsukuba, Ibaraki, 305-0843, Japan.
Nobuo KawaharaResearch Center for Medicinal Plant Resources, National Institutes of Biomedical Innovation, Health and Nutrition, 1-2 Hachimandai, Tsukuba, Ibaraki, 305-0843, Japan.
Takuro MaruyamaDivision of Pharmacognosy, Phytochemistry and Narcotics, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan.ORCID http://orcid.org/0000-0002-6393-3989
Katsuko KomatsuDepartment of Medicinal Resources, Institute of Natural Medicine, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan. katsukok@inm.u-toyama.ac.jp.ORCID http://orcid.org/0000-0002-0833-7199

Funding

Japan Agency for Medical Research and Development JP17ak0101046h002Japan Society for the Promotion of Science 15H05268Japan Society for the Promotion of Science 15K07993Japan Society for the Promotion of Science 24406005Japan Society for the Promotion of Sciences 18K06728
6 · The paper itself

Abstract

Saposhnikoviae Radix (SR) is a commonly used crude drug that is obtained from the root and rhizome of Saposhnikovia divaricata which is distributed throughout China, Korea, Mongolia, and Russia. To evaluate the quality of Mongolian S. divaricata, metabolomic profiling of 43 plant specimens from different regions of Mongolia, as well as 8 SR samples and 2 plant specimens from China, were conducted by liquid chromatography-ion-trap-time-of-flight-mass spectrometer (LC-IT-TOF-MS). LC-MS profiles of the specimens showed uniformity and 30 compounds were tentatively identified, including 13 chromones and 17 coumarins. Among them, 16 compounds were isolated and unambiguously verified by comparing them with the spectroscopic data of standard compounds. Orthogonal partial least squares-discriminant analysis (OPLS-DA) based on LC-MS data from 7 Mongolian specimens and 8 Chinese SR samples as well as 2 plant specimens revealed that these 2 groups were clearly distinguishable and that Mongolian specimens were characterized by an abundance of prim-O-glucosylcimifugin (1). Moreover, the OPLS-DA of the Mongolian specimens showed that they can be discriminated by their growing regions based on the content of 8 chromones. The total content of dihydrofurochromones 1-3 was relatively higher in the specimens from Khalkhgol in the far eastern part of Mongolia, while contents of 10, 11, 15, and 16 were higher in those from Holonbuir in the eastern part. Based on this research, the roots of S. divaricata from Mongolia have potential as a new resource of SR in Kampo medicine.

Indexed as

ApiaceaeChinaChromatography, High Pressure LiquidChromatography, LiquidChromonesCoumarinsDrugs, Chinese HerbalMedicine, KampoMongoliaMonosaccharidesPlant RootsRhizomeTandem Mass SpectrometryXanthenesChromonesCoumarinsDrugs, Chinese HerbalMonosaccharidesprim-O-glucosylcimifuginXanthenesLC–IT–TOF–MS/MSMetabolomic profilingMongoliaMultivariate statistical analysisSaposhnikovia divaricataSaposhnikoviae Radix

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.